Patients receiving mineralocorticoid therapy typically have which priority nursing diagnosis?

In the context of mineralocorticoid therapy, the priority nursing diagnosis often revolves around the effects that these agents can have on fluid and electrolyte balance in patients. Mineralocorticoids, such as aldosterone, increase the retention of sodium and water while promoting the excretion of potassium. This can lead to fluid retention and possible hypertension if the therapy is not monitored closely.

The choice that highlights "potential for alteration in skin integrity" acknowledges that excessive fluid retention may result in edema, which can stretch the skin and lead to skin breakdown or pressure ulcers, especially in individuals with limited mobility. Therefore, skin integrity must be actively monitored as fluid balance influences the skin's overall health and condition.

While other options reflect valid concerns in patients undergoing various therapies, they don't specifically align with the primary effects of mineralocorticoids. Fluid retention and its consequences on skin integrity should be prioritized. Recognizing the potential for skin integrity issues allows for proactive interventions to prevent complications associated with fluid overload.